Publication list
2022
Lovas, S.,
Obajed Al-Ali, N.,
Varga, G.,
Szita, V.,
Alizadeh, H.,
Plander, M.,
Rajnics, P.,
Illés, Á.,
Szemlaky, Z.,
Mikala, G.,
Váróczy, L.:
Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients: Real-World Data From Hungary.
Pathol. Oncol. Res. 28 1-7, 2022.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
2021
Varga, G.,
Tóth, A.,
Virág, R.,
Csukly, Z.,
Hardi, A.,
Gaál-Weisinger, J.,
Nagy, Z.,
Altai, E.,
Rencsik, A.,
Plander, M.,
Szendrei, T.,
Kórád, K.,
Radványi, G.,
Rottek, J.,
Deák, B.,
Szaleczky, E.,
Schneider, T.,
Kohl, Z.,
Kosztolányi, S.,
Alizadeh, H.,
Lengyel, Z.,
Modok, S.,
Borbényi, Z.,
Lovas, S.,
Váróczy, L.,
Illés, Á.,
Rajnics, P.,
Masszi, T.,
Mikala, G.:
Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: results of Real-Life Data From 11 Hungarian Centers.
Pathol. Oncol. Res. 27 1-6, 2021.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
Q2 Pathology and Forensic Medicine
2019
Lovas, S.,
Varga, G.,
Farkas, P.,
Masszi, T.,
Wohner, N.,
Bereczki, Á.,
Adamkovich, N.,
Borbényi, Z.,
Szomor, Á.,
Alizadeh, H.,
Szaleczky, E.,
Wolf, K.,
Schneider, T.,
Plander, M.,
Szendrei, T.,
Csacsovszki, O.,
Csukly, Z.,
Rajnics, P.,
Egyed, M.,
Nagy, Z.,
Rejtő, L.,
Illés, Á.,
Mikala, G.,
Váróczy, L.:
Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients.
Int. J. Hematol. 110 (5), 559-565, 2019.
2018
Palatka, K.,
Kacska, S.,
Lovas, S.,
Garai, I.,
Varga, J.,
Galuska, L.:
The potential role of FDG PET-CT in the characterization of the activity of Crohn's disease, staging follow-up and prognosis estimation: a pilot study.
Scand. J. Gastroenterol. 53 (1), 24-30, 2018.
Rencz, F.,
Lakatos, P.,
Gulácsi, L.,
Brodszky, V.,
Kürti, Z.,
Lovas, S.,
Banai, J.,
Herszényi, L.,
Cserni, T.,
Molnár, T.,
Péntek, M.,
Palatka, K.:
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
Qual. Life Res. 28 (1), 141-152, 2018.
Journal metrics:
Q1 Public Health, Environmental and Occupational Health
2013
Galuska, L.,
Kis, S.,
Fedinecz, N.,
Palatka, K.,
Lovas, S.,
Garai, I.,
Varga, J.:
Assessment of crohn's disease activity by FDG PET-CT (024).
Nucl. Med. Rev. Cent. E. Eur. 16 (Suppl.), A12, 2013.
updated: 2023-05-28, 01:28
